Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;34(4):945-949.
doi: 10.1007/s40520-021-02070-z. Epub 2022 Mar 17.

Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency

Affiliations

Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency

Sarah Damanti et al. Aging Clin Exp Res. 2022 Apr.

Abstract

Objective: Exploring the association between frailty and mortality in a cohort of patients with COVID-19 respiratory insufficiency treated with continuous positive airway pressure.

Methods: Frailty was measured using a Frailty Index (FI) created by using the baseline assessment data on comorbidities and body mass index and baseline blood test results (including pH, lactate dehydrogenase, renal and liver function, inflammatory indexes and anemia). FI > 0.25 identified frail individuals.

Results: Among the 159 included individuals (81% men, median age of 68) frailty was detected in 69% of the patients (median FI score 0.3 ± 0.08). Frailty was associated to an increased mortality (adjusted HR 1.99, 95% CI 1.02-3.88, p = 0.04).

Conclusions: Frailty is highly prevalent among patients with COVID-19, predicts poorer outcomes independently of age. A personalization of care balancing the risk and benefit of treatments (especially the invasive ones) in such complex patients is pivotal.

Keywords: COVID-19; Frailty; Mortality; Non-invasive ventilation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Hubbard RE, Maier AB, Hilmer SN, et al. Frailty in the face of COVID-19. Age Ageing. 2020;49:499–500. doi: 10.1093/ageing/afaa095. - DOI - PMC - PubMed
    1. Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus—a perspective. Expert Rev Clin Immunol. 2020;16:465–470. doi: 10.1080/1744666X.2020.1750954. - DOI - PMC - PubMed
    1. Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013;381:752–762. doi: 10.1016/S0140-6736(12)62167-9. - DOI - PMC - PubMed
    1. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395:1225–1228. doi: 10.1016/S0140-6736(20)30627-9. - DOI - PMC - PubMed